Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · IEX Real-Time Price · USD
0.280
-0.017 (-5.69%)
At close: Jul 2, 2024, 4:00 PM
0.294
+0.014 (5.00%)
After-hours: Jul 2, 2024, 7:53 PM EDT
Lyra Therapeutics Stock Forecast
LYRA's stock price has decreased by -93.17% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Lyra Therapeutics stock have an average target of 4.50, with a low estimate of 0.50 and a high estimate of 11. The average target predicts an increase of 1,507.14% from the current stock price of 0.28.
Analyst Consensus: Buy
* Price targets were last updated on May 7, 2024.
Analyst Ratings
The average analyst rating for LYRA stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 3 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $2 | Strong Buy → Hold | Downgrades | $2 | +614.29% | May 7, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $10 → $0.5 | Strong Buy → Hold | Downgrades | $10 → $0.5 | +78.57% | May 7, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +4,185.71% | May 1, 2024 |
Financial Forecast
Revenue This Year
1.61M
from 1.56M
Increased by 3.47%
Revenue Next Year
821.92K
from 1.61M
Decreased by -49.01%
EPS This Year
-1.29
from -1.26
EPS Next Year
-1.08
from -1.29
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.2M | 1.7M | 19.8M | 40.6M | 176.8M |
| Avg | 1.6M | 821,916 | 8.2M | 35.0M | 127.0M |
| Low | 490,000 | n/a | n/a | 29.3M | 78.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 43.6% | 3.5% | 2,314.5% | 391.9% | 405.9% |
| Avg | 3.5% | -49.0% | 903.5% | 323.8% | 263.2% |
| Low | -68.5% | - | - | 255.3% | 125.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.22 | -0.55 | -0.77 | -1.00 | -0.30 |
| Avg | -1.29 | -1.08 | -1.18 | -1.38 | -0.43 |
| Low | -1.36 | -1.25 | -1.37 | -1.71 | -0.55 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.